biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by rustycaton Oct 02, 2017 11:04am

133 Views

Post# 26766286

RE:biOasis Appoints Christopher P. Lowe as CFO & Board Advisor

Not to belabor the obvious, Dr. Day is clearing off the Checkers Board and setting up the Chess Board. But, I would hazard a guess that He's thinking a Corporate move to the US and a Nasdaq listing with the stock firmly above $5 within the next two years (yeah this is wild conjecture).

Bullboard Posts

Investing with insurance and protection